Cardlytics（CDLX）株式概要
Cardlytics, Inc.は、米国と英国で広告プラットフォームを運営している。 詳細
CDLX Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Cardlytics, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$3.81 |
| 52週高値 | US$32.80 |
| 52週安値 | US$3.49 |
| ベータ | 0.67 |
| 1ヶ月の変化 | -11.81% |
| 3ヶ月変化 | -42.71% |
| 1年変化 | -69.52% |
| 3年間の変化 | -97.18% |
| 5年間の変化 | -99.52% |
| IPOからの変化 | -97.15% |
最新ニュース
Recent updates
ナラティブ更新 • Aug 06
CDLX: Reverse Split And Profitability Outlook Will Drive Future Repricing
Analysts have trimmed their Cardlytics fair value estimate from $10.75 to $8.50, pointing to updated assumptions for revenue trends, profitability, and future P/E that informed the latest price target cut reported in recent research. What’s in the News for Cardlytics Cardlytics received a Nasdaq notice on June 3, 2026, stating that its common stock had closed below the US$1.00 minimum bid price requirement for 30 consecutive business days, triggering a compliance period that runs until November 30, 2026.
ナラティブ更新 • Jul 14
CDLX: Reverse Split And Margin Outlook Will Support A Higher Price
Analysts have trimmed their Cardlytics price targets by $0.25. They are factoring in a lower fair value estimate, a slightly higher discount rate, and expectations for weaker revenue growth, despite modestly stronger profit margins and a lower future P/E assumption.
ナラティブ更新 • Jun 30
CDLX: Reverse Split And Nasdaq Compliance Efforts Will Drive Future Repricing Potential
Analysts have reduced their Cardlytics price target from $15.00 to $1.50, citing updated assumptions of slightly weaker revenue growth and profit margins, along with a modestly higher future P/E multiple. What’s in the News for Cardlytics On June 3, 2026, Cardlytics received a notice from Nasdaq that its common stock had closed below US$1.00 per share for 30 consecutive business days, triggering a deficiency under Nasdaq Listing Rule 5550(a)(2).ナラティブ更新 • Jun 16
CDLX: Reverse Split And Margin Outlook Will Drive Future Repricing
Analysts have raised their fair value estimate for Cardlytics to $10.75 from $1.08, citing updated price target work that incorporates unchanged discount rate assumptions, a slightly higher long term profit margin outlook, and a modestly lower future P/E multiple. What’s in the News for Cardlytics Cardlytics plans a 1 for 10 reverse stock split of its common stock, with the company’s shares expected to begin trading on a split adjusted basis on The Nasdaq Global Market on June 8, 2026, and the new CUSIP number set as 14161W303.ナラティブ更新 • Jun 02
CDLX: Reset Expectations And Partner Exit Will Drive Future Repricing
Analysts have edged Cardlytics' fair value estimate up to about $1.08 per share, while tightening assumptions around discount rate, revenue contraction, profit margins and future P/E. This reflects recent price target cuts to $1 to $1.25 that they see as better aligned with updated guidance and the impact of the BofA exit and Bridg sale.ナラティブ更新 • May 15
CDLX: Reset Guidance And Banking Shifts Will Drive Future Repricing Potential
Narrative update on Cardlytics The analyst price target for Cardlytics has shifted from $1.25 to $1.50, with analysts pointing to updated assumptions around discount rates, revenue trends, margins, and future P/E after recent resets in expectations following Q4 results, Q1 guidance, and the impact of the BofA exit and Bridg divestiture. Analyst Commentary Recent research has centered on how Cardlytics should be valued after its Q4 results, Q1 guidance, and the announced BofA exit and Bridg divestiture.分析記事 • May 11
Cardlytics, Inc. (NASDAQ:CDLX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Cardlytics, Inc. ( NASDAQ:CDLX ) just released its latest first-quarter results and things are looking bullish...ナラティブ更新 • May 01
CDLX: Reset Expectations And Banking Partner Shifts Will Drive Future Repricing
Analysts have nudged Cardlytics' average price target lower to about $1, with cuts from $2 to $1 and from $1.50 to $1.25. These changes reflect updated views after Q4 results, Q1 guidance, and the expected impact of the BofA exit and Bridg divestiture.ナラティブ更新 • Apr 17
CDLX: Reset Guidance And BofA Exit Will Drive Upside Potential
Narrative Update on Cardlytics Analysts have cut their Cardlytics price targets to a range of about $1 to $1.25, citing Q1 guidance that resets expectations following the Bank of America exit and Bridg divestiture and leaves the stock in what they describe as "show me" territory. Analyst Commentary Recent research updates underline that Q1 guidance and the effects of the Bank of America exit and Bridg divestiture are central to how analysts are framing Cardlytics today.ナラティブ更新 • Apr 03
CDLX: Reset Expectations And Partner Changes Will Shape Future Repricing
Analysts have trimmed Cardlytics' implied fair value from about $1.29 to roughly $1.04. This reflects recent price target cuts to $1 and $1.25 as they factor in softer revenue expectations and the impact of the BofA exit and Bridg divestiture.ナラティブ更新 • Mar 20
CDLX: Reset Guidance And One Bank Exit Will Define Upside Potential
Narrative update on Cardlytics Analysts have trimmed Cardlytics' implied fair value from about $2.00 to roughly $1.25, reflecting lower price targets around $1.00 to $1.25 after Q1 guidance reset expectations for revenue trends, margins and future P/E as the business adjusts to the BofA exit and Bridg divestiture. Analyst Commentary Recent Street research has centered on recalibrated price targets around Q1 guidance and the operational impact of the BofA exit and Bridg divestiture.ナラティブ更新 • Mar 06
CDLX: Reset Expectations And CFO Return Will Support Future Rerating
Analysts have trimmed their Cardlytics price target from $1.50 to $1.25, reflecting updated assumptions around fair value, revenue trends, and profitability following recent guidance resets and business changes. Analyst Commentary Recent commentary around the reduced US$1.25 price target centers on how quickly Cardlytics can adjust to its updated outlook and business mix after the Q1 guidance reset, the BofA exit, and the Bridg divestiture.分析記事 • Jan 08
Cardlytics, Inc. (NASDAQ:CDLX) Stock Catapults 30% Though Its Price And Business Still Lag The Industry
Those holding Cardlytics, Inc. ( NASDAQ:CDLX ) shares would be relieved that the share price has rebounded 30% in the...Seeking Alpha • Oct 06
Cardlytics: Debt Overhang Casts Shadow On Upside
Summary Cardlytics is dealing with a significant headwind in Q3 due to restrictions from its largest bank partner. CDLX sold off sharply following Q2 results, but has since rallied following a bullish report from Citron Research. Management is targeting positive FCF through growth with its newest large bank partner while also substantially lowering operating expenses. Debt remains the biggest risk, though the earliest maturity is not until April 2028. I remain cautious until I see evidence of sequential growth and improving cash burn. Read the full article on Seeking Alphaナラティブ更新 • Aug 08
Bank Partnerships And Data-Driven Marketing Will Shape Future Markets
The notable downward revision in Cardlytics’ price target reflects sharply reduced revenue growth forecasts and a higher discount rate, resulting in a new consensus fair value of $2.10. What's in the News Cardlytics provided Q3 2025 revenue guidance of $52.2 million to $58.2 million.分析記事 • Jul 23
Revenues Tell The Story For Cardlytics, Inc. (NASDAQ:CDLX) As Its Stock Soars 64%
Cardlytics, Inc. ( NASDAQ:CDLX ) shares have continued their recent momentum with a 64% gain in the last month alone...分析記事 • Jul 05
Is Cardlytics (NASDAQ:CDLX) Using Debt Sensibly?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • May 29
Cardlytics, Inc. (NASDAQ:CDLX) Soars 30% But It's A Story Of Risk Vs Reward
Cardlytics, Inc. ( NASDAQ:CDLX ) shareholders are no doubt pleased to see that the share price has bounced 30% in the...分析記事 • Apr 07
Why Investors Shouldn't Be Surprised By Cardlytics, Inc.'s (NASDAQ:CDLX) 30% Share Price Plunge
Unfortunately for some shareholders, the Cardlytics, Inc. ( NASDAQ:CDLX ) share price has dived 30% in the last thirty...
新しいナラティブ • Apr 03
US Neobank And Taiwan Office Will Unlock New Markets
Expansion into new sectors and partnerships with financial institutions and neobanks is expected to diversify the customer base and boost revenue.分析記事 • Mar 11
Cardlytics (NASDAQ:CDLX) Has Debt But No Earnings; Should You Worry?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Feb 21
Revenues Tell The Story For Cardlytics, Inc. (NASDAQ:CDLX)
It's not a stretch to say that Cardlytics, Inc.'s ( NASDAQ:CDLX ) price-to-sales (or "P/S") ratio of 0.5x right now...Seeking Alpha • Feb 13
Cardlytics: Short-Term Headwinds Drive Long-Term Success
Summary Cardlytics, Inc. offers an asymmetric investment opportunity for those who can handle stock price volatility and slow business progress. Recent issues with ad deliveries have impacted revenue and market sentiment but positioned the company for long-term success. The shift to engagement-based pricing is expected to drive broader platform adoption. Trading at just 0.51x P/S and 1.10x EV/Revenue, Cardlytics presents significant upside potential from current valuations. Amex Partnership could add $600 million in market value based on $35 million in incremental EBITDA for 2025. Read the full article on Seeking Alpha分析記事 • Jan 10
At US$3.35, Is It Time To Put Cardlytics, Inc. (NASDAQ:CDLX) On Your Watch List?
Cardlytics, Inc. ( NASDAQ:CDLX ), might not be a large cap stock, but it saw significant share price movement during...Seeking Alpha • Dec 07
Cardlytics Continues Revenue Contraction Amid Worsening Economics
Summary Cardlytics, Inc. beat revenue and earnings estimates, but faces declining unit economics and revenue stabilization challenges. The AdTech market is projected to grow significantly, yet CDLX struggles with delivery inefficiencies, declining ARPU, and advertiser hesitancy, impacting its financial performance. Recent financial trends show falling revenue, negative operating income, and high stock-based compensation, with significant cash burn and a 52.1% stock price decline over the past year. Management's turnaround efforts may take several quarters, with increased R&D spending expected to further negatively affect operating results. My outlook on CDLX is to sell. Read the full article on Seeking Alpha分析記事 • Nov 23
Estimating The Intrinsic Value Of Cardlytics, Inc. (NASDAQ:CDLX)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cardlytics fair value estimate is US$3.50 Current share price...分析記事 • Nov 05
After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar
Cardlytics, Inc. ( NASDAQ:CDLX ) shareholders are no doubt pleased to see that the share price has bounced 27% in the...分析記事 • Oct 15
Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Seeking Alpha • Sep 17
Cardlytics: Execution Risks Are Elevated, But Reasons For Optimism Remain (Maintain Hold Rating)
Summary Shares have fallen nearly 50% since the Q2 earnings report, which came in well below management’s guidance. With Q3 guidance pointing to further weakness, the company’s financial health hinges on management’s execution towards solving the ongoing issues on its ads platform. Assuming no additional setbacks, the company should return to growth next year and generate positive FCF. While risks remain high, the current valuation is undemanding, leading me to maintain a Neutral rating. Read the full article on Seeking Alpha分析記事 • Aug 09
Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk
Cardlytics, Inc. ( NASDAQ:CDLX ) shareholders that were waiting for something to happen have been dealt a blow with a...Seeking Alpha • Jul 02
Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain
Summary Cardlytics shares have declined significantly after Q1 earnings came in below management’s guidance. Key metrics show that the business is performing well. Recent steps taken by management have extended its debt until 2029, leaving the company in a more stable financial position. CDLX has multiple growth levers and significant risks that investors should consider. Read the full article on Seeking Alpha分析記事 • May 31
Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors
The Cardlytics, Inc. ( NASDAQ:CDLX ) share price has softened a substantial 30% over the previous 30 days, handing back...Seeking Alpha • Apr 17
The Power Of Cardlytics' Data Partnerships Including Bank of America
Summary Cardlytics recently appointed Liane Hornsey to its Board of Directors, which could attract new investors and accelerate hiring and productivity. The company offers a suite of solutions for advertising, marketing, and customer engagement through its own mobile application and partnerships with financial institutions. Future growth projects, synergies, database integration, and new partnerships have the potential to drive net sales growth and increase investor attention. Read the full article on Seeking Alpha分析記事 • Apr 10
Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors
Despite an already strong run, Cardlytics, Inc. ( NASDAQ:CDLX ) shares have been powering on, with a gain of 81% in the...株主還元
| CDLX | US Media | US 市場 | |
|---|---|---|---|
| 7D | -5.2% | -11.0% | 0.09% |
| 1Y | -69.5% | -17.9% | 19.0% |
業界別リターン: CDLX過去 1 年間で-17.9 % の収益を上げたUS Media業界を下回りました。
リターン対市場: CDLXは、過去 1 年間で19 % のリターンを上げたUS市場を下回りました。
価格変動
| CDLX volatility | |
|---|---|
| CDLX Average Weekly Movement | 11.7% |
| Media Industry Average Movement | 9.1% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: CDLXの株価は、 US市場と比較して過去 3 か月間で変動しています。
時間の経過による変動: CDLXの 週次ボラティリティ は過去 1 年間で20%から12%に減少しましたが、依然としてUS株の 75% よりも高くなっています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2008 | 224 | Amit Gupta | www.cardlytics.com |
は、米国と英国で広告プラットフォームを運営している。同社は、マーケティング担当者がオンライン、モバイルアプリケーション、電子メール、さまざまなリアルタイム通知などのデジタルチャネルを通じて顧客にリーチすることを可能にする独自のネイティブバンク広告チャネルであるCardlyticsプラットフォームと、商品レベルの購買データを含む加盟店データパートナーからのPOSデータを活用し、マーケティング担当者が分析やターゲットロイヤルティマーケティングを実行し、マーケティングの効果を測定することを可能にする顧客データプラットフォームであるBridgプラットフォームを提供している。Cardlytics社は2008年に設立され、ジョージア州アトランタに本社を置いている。
Cardlytics, Inc. 基礎のまとめ
| CDLX 基礎統計学 | |
|---|---|
| 時価総額 | US$22.38m |
| 収益（TTM） | -US$109.56m |
| 売上高(TTM) | US$190.00m |
0.1x
P/Sレシオ-0.2x
PER（株価収益率CDLX は割高か？
公正価値と評価分析を参照収益と収入
| CDLX 損益計算書（TTM） | |
|---|---|
| 収益 | US$190.00m |
| 売上原価 | US$97.13m |
| 売上総利益 | US$92.87m |
| その他の費用 | US$202.43m |
| 収益 | -US$109.56m |
直近の収益報告
Jun 30, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | -18.61 |
| グロス・マージン | 48.88% |
| 純利益率 | -57.67% |
| 有利子負債／自己資本比率 | -1,152.3% |
CDLX の長期的なパフォーマンスは？
過去の実績と比較を見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/08/11 08:44 |
| 終値 | 2026/08/11 00:00 |
| 収益 | 2026/06/30 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Cardlytics, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11
| アナリスト | 機関 |
|---|---|
| Omar Dessouky | BofA Global Research |
| Jason Kreyer | Craig-Hallum Capital Group LLC |
| Robert Coolbrith | Evercore ISI |